Article Details
Retrieved on: 2024-04-13 13:26:24
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the resilient performance of the healthcare sector in the stock market and highlights innovation, particularly the rise of new weight-loss drugs like semaglutide from companies such as Novo Nordisk and Eli Lilly. It also mentions the shift toward value-based healthcare models in the U.S. and suggests ETFs for investing in these trends.
Article found on: www.theglobeandmail.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here